Showing results (151-160 of 259) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
Endogenous axon guiding chemorepulsant semaphorin-3F inhibits the growth and metastasis of colorectal carcinomaFeng Wu, Qi Zhou, Jing Yang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 14, 2016
Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cellsZhipeng Wang, Jiao Tan, Christopher McConville, et al.
Science Advances|October 17, 2025
Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposurePeidi Yin, Jigui Yang, Yiyang Jiang, et al.
Plos Genetics|December 8, 2021
Correction: Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple TargetsFang Zheng, Yi-Ji Liao, Mu-Yan Cai, et al.
Molecular Cancer Therapeutics|April 27, 2011
Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticleHong Yao, Samuel S Ng, Long-Fei Huo, et al.
Cancer Letters|November 26, 2018
Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasionMian-Fu Cao, Lu Chen, Wei-Qi Dang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 7, 2018
Mitochondrial pyruvate carrier 1 functions as a tumor suppressor and predicts the prognosis of human renal cell carcinomaXiao-Peng Tang, Qian Chen, Yi Li, et al.
Cell Stem Cell|November 4, 2017
Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic EfficacyWenchao Zhou, Cong Chen, Yu Shi, et al.
Oncoimmunology|January 31, 2022
Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastomaKaidi Yang, Yu Shi, Min Luo, et al.
Plos Genetics|February 19, 2015
Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targetsFang Zheng, Yi-Ji Liao, Mu-Yan Cai, et al.
Pageof 26